You are not currently logged in.
Access JSTOR through your library or other institution:
Hormonal Contraception and HIV Disease Progression
Elizabeth Stringer and Erik Antorisen
Clinical Infectious Diseases
Vol. 47, No. 7 (Oct. 1, 2008), pp. 945-951
Published by: Oxford University Press
Stable URL: http://www.jstor.org/stable/40307871
Page Count: 7
You can always find the topics here!Topics: T lymphocytes, Contraception, HIV, Infections, HIV infections, Disease progression, AIDS, Estrogens, Viral load, HIV 1
Were these topics helpful?See somethings inaccurate? Let us know!
Select the topics that are inaccurate.
Preview not available
The majority of the 15.4 million human immunodeficiency virus (HlV)-infected women worldwide are of child-bearing age and need access to contraception. Hormonal methods of contraception are safe, acceptable, and effective in preventing unwanted pregnancies. Many published studies have examined the impact of hormonal contraception on HIV disease acquisition and transmissibility. Far fewer have investigated the relationship between hormonal contraception and HIV disease progression. This review examines available data on this relationship from clinical, animal, and immunological studies. Several clinical studies suggest an overall effect but are not definitive, and the mechanisms behind HIV disease progression are unclear. Animal and immunological data suggest that immunomodulation by hormonal contraceptive methods may affect the immune response to HIV infection. Additional work is needed in this area to elucidate the possible relationship between hormonal methods for birth control and progression to acquired immunodeficiency syndrome in HIV-infected women.
Clinical Infectious Diseases © 2008 Oxford University Press